Filgrastim biosimilar (Merck)

非格司亭生物类似药（默沙东）

Report date: 2024/03/11 20:05:20

Base Information

Drug NameFilgrastim biosimilar (Merck)
Drug Alias Name非格司亭生物仿制药（默沙东）rhG-CSF (Merck)重组人粒细胞刺激因子（默沙东）Recombinant human granulocyte macrophage colony stimulating factor (Merck)INS-19 +[6] 
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInsmedMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInsmedMerck Sharp & Dohme Corp
Active IndicationsN/A
Inactive IndicationsNeutropenia

Other Information

ATC CodeL03AA02
Related LinksDrugBank